Stem Cells as an Emerging Paradigm in Stroke 3: Enhancing the Development of Clinical Trials

Journal article

Open access

Peer reviewed

Sean I Savitz, Steven C Cramer, Lawrence Wechsler, STEPS 3 Consortium and Dileep Raghvendra Yavagal

Stroke (1970), Vol.45(2), pp.634-639

2014

PMCID: PMC5823253

PMID: 24368562

Abstract

Biological and medical sciences

Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy

Medical sciences

Nervous system (semeiology, syndromes)

Neurology

Vascular diseases and vascular malformations of the nervous system

url

https://doi.org/10.1161/STROKEAHA.113.003379View

Published (Version of record) Open

4 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.102 Stem Cell Research; 1.102.110 Mesenchymal Stem Cells
Web Of Science research areas: Clinical Neurology; Peripheral Vascular Disease
ESI research areas: Neuroscience & Behavior

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Stem Cells as an Emerging Paradigm in Stroke 3: Enhancing the Development of Clinical Trials
Creators: Sean I Savitz - The University of Texas at Austin
Steven C Cramer - University of California, Irvine
Lawrence Wechsler - University of Pittsburgh
STEPS 3 Consortium
Dileep Raghvendra Yavagal - UMMG Department of Neurology
Publication Details: Stroke (1970), Vol.45(2), pp.634-639
Publisher: Lippincott Williams & Wilkins
Academic Unit: Miller School of Medicine; UMMG Department of Neurology
Language: English
Resource Type: Journal article
PMID: 24368562
PMCID: PMC5823253
Record Identifier: 991031713642302976